Jefferies Financial Group Forecasts Strong Price Appreciation for Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare (NYSE:THC) had its target price hoisted by analysts at Jefferies Financial Group from $250.00 to $265.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group’s price target points to a potential upside of 14.77% from the stock’s previous close.

Several other equities analysts also recently issued reports on the stock. Mizuho upped their price objective on shares of Tenet Healthcare from $194.00 to $225.00 and gave the company an “outperform” rating in a report on Friday, October 17th. TD Cowen restated a “buy” rating on shares of Tenet Healthcare in a research note on Thursday. KeyCorp lifted their price objective on shares of Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a research note on Thursday. Wells Fargo & Company dropped their price objective on shares of Tenet Healthcare from $252.00 to $229.00 and set an “overweight” rating on the stock in a report on Wednesday, January 7th. Finally, Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 31st. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $242.82.

Tenet Healthcare Price Performance

Shares of THC opened at $230.90 on Thursday. The company has a 50 day moving average of $198.82 and a two-hundred day moving average of $194.69. The company has a market cap of $20.29 billion, a price-to-earnings ratio of 14.91, a price-to-earnings-growth ratio of 0.97 and a beta of 1.44. The company has a quick ratio of 1.64, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. Tenet Healthcare has a twelve month low of $109.82 and a twelve month high of $235.77.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same quarter in the prior year, the business posted $3.44 EPS. The business’s revenue for the quarter was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, analysts predict that Tenet Healthcare will post 12.24 earnings per share for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the transaction, the director owned 28,480 shares in the company, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.81% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of THC. Triumph Capital Management purchased a new stake in Tenet Healthcare during the third quarter worth $25,000. Activest Wealth Management acquired a new position in shares of Tenet Healthcare in the fourth quarter worth about $26,000. Elyxium Wealth LLC purchased a new stake in shares of Tenet Healthcare during the 4th quarter worth about $29,000. William B. Walkup & Associates Inc. purchased a new position in shares of Tenet Healthcare in the 3rd quarter valued at about $32,000. Finally, Canada Pension Plan Investment Board acquired a new position in Tenet Healthcare in the 2nd quarter worth about $35,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.